It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2018.
2018 | Ahmedabad, Gujarat, India | ActiveOncobiotek Formulations Private Limited, a active private limited company, was established on 18 June 2018 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24290GJ2018PTC102902. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Employing 52 professional, Its leadership includes Rajesh Omprakash Sharma (Director), Haresh Hondraj Khetwani (Director). It holds ₹8.82 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 03, Krishna Park,Ahed Arpan School Opp Mansovar, Near Rajdhani Bunglows,Vas, Tral, Ahmedabad, Gujarat, 382449.
U24290GJ2018PTC102902
102902
18 June 2018
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Oncobiotek Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Omprakash Sharma | Director | 18 Jun 2018 | Current |
| Haresh Hondraj Khetwani | Director | 18 Jun 2018 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oncobiotek Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 60.63% increase. The company also saw a substantial fall in profitability, with a 50.72% decrease in profit. The company's net worth Soared by an impressive increase of 12.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Oncobiotek Formulations had a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹8,820,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2021 | Others | ₹8.82 M | Open |
Explore comprehensive loan charge details -
Oncobiotek Formulations has a workforce of 52 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Oncobiotek Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oncobiotek Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Oncobiotek Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Oncobiotek Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.
Progress on A charge with Others amounted to Rs. 8.82 M with Charge ID 100497321 was registered on 26 Oct 2021. was documented.
Progress on Rajesh Omprakash Sharma was appointed as a Director was appointed as a Director on 18 Jun 2018 & has been associated with this company since 7 years 6 months . was documented.
The activity Haresh Hondraj Khetwani was appointed as a Director was appointed as a Director on 18 Jun 2018 & has been associated with this company since 7 years 6 months . was completed.
Progress on Oncobiotek Formulations Private Limited was registered on 18 Jun 2018 with Roc Ahmedabad & aged 7 years 6 months as per MCA records. was documented.
The CIN of Oncobiotek Formulations Private Limited is U24290GJ2018PTC102902.
Oncobiotek Formulations Private Limited is headquartered at 03, Krishna Park,Ahed Arpan School Opp Mansovar, Near Rajdhani Bunglows,Vas, Tral, Ahmedabad, Gujarat, 382449.
Oncobiotek Formulations Private Limited was incorporated on 18 June 2018.
The current directors of Oncobiotek Formulations Private Limited are
The primary industry of Oncobiotek Formulations Private Limited is Manufacturing.
Oncobiotek Formulations Private Limited is unlisted.
The authorized capital of Oncobiotek Formulations Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX